Sustained Acoustic Medicine (SAM) is an FDA-approved ultrasound treatment that heals a wide range of injuries and significantly reduces pain – without drugs or surgery. Manufactured by ZetrOZ Systems in Trumbull, CT, SAM is a gamechanger for chronic pain patients and the Veteran Health Administration’s strategic initiative to reduce opioid abuse.
Military veteran Dr. Ervin Rodriguez, who served as a First Sergeant in the United States Army, experienced a life-changing improvement in the state of multiple chronic soft-tissue injury sites after treating them with the SAM® wearable, says a press release.
“Five months ago, I was introduced to the SAM® ultrasound unit through my occupational therapist at the James A. Haley Veterans Affairs hospital in Tampa, Florida. Several areas of my body have responded well to daily use of the device, and I have felt at minimum a 20% improvement. The SAM® unit has definitely surpassed my expectations,” Dr. Rodriguez said.
A double-blind RCT study published recently in the Journal of Pain Research by the Orthopaedic Foundation, found that low-intensity continuous ultrasound treatment significantly reduced upper trapezius myofascial pain of the neck and shoulder.
SAM® effectively treats the following:
- Arthritis and joint pain
- Back and muscle pain
- Post-operative recovery and pain management
- Tendinitis of the shoulder, elbow, knee and ankle
By stimulating blood flow for multiple hours per day to a localized region of the user’s body, SAM sends a powerful flow of nutrients to the site of an injury. The wearable device accelerates biological healing processes and reduces pain by harnessing the sustained delivery of high-frequency acoustic waves. In this way, SAM stimulates the body’s natural repair process. The device promotes collagen matrix production and cellular replication to heal damaged tissue. It accomplishes this by gently massaging users’ cells – making the treatment safe and non-invasive.
United States Veterans and members of the military get to experience the many benefits of SAM through homecare health benefits. Made in the United States, the treatment is approved by the United States government to treat active duty service members and veterans.
“The courageous men and women who serve in our military are willing to make the ultimate sacrifice. At the very least, they deserve an active life free of debilitating pain. I am humbled and honored to be part of the solution relieving them of pain that, historically, has afflicted many veterans for the remainder of their lives. It makes my nearly life-long devotion to developing bioregenerative technologies worthwhile and very gratifying,” said Dr. George Lewis, chief executive officer of ZetrOZ Systems.